SAR421869
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR421869, covering 2020-03-18 to 2026-01-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1B [Phase 2]